Covaxin offers protection against beta and delta variants, says study
The Hindu
The study was carried out by researchers from National Institute of Virology, ICMR and Bharat Biotech.
A small study claims that from both the delta (B.1.617.2) and beta (B.1.351) variants. Also read: The study evaluated the neutralisation potential in people vaccinated with Covaxin and found that there was a 3- and 2.7-fold reduction in neutralisation titers against the beta (B.1.351) and delta (B.1.617.2) variants, respectively. In comparison, the reduction in neutralisation titers with sera from people who have recovered from COVID-19 were 3.3- and 4.6-fold against the beta and delta variants, respectively. The results of the study were preprint server on June 7. Preprints are yet to be peer-reviewed.
Explore the necessity, types, challenges, and potential of bioremediation in India for environmental restoration and public health.
Researchers in India uncover genetic factors linked to early oral cancer onset in tobacco chewers, enhancing cancer prediction and prevention.
Mahindra’s XEV 9S is a modern, family-focused electric SUV with premium design, a spacious tech-rich cabin, refined performance and advanced safety features. Discover variants, pricing and real-world impressions in our detailed review.
Samantha interview: On pickleball, her battles with a rare autoimmune condition and learnings
Experience the thrilling Akkulam Glass Bridge in Thiruvananthapuram, offering stunning views and adventure activities for all ages.
Climate scientists and advocates long held an optimistic belief that once impacts became undeniable, people and governments would act. This overestimated our collective response capacity while underestimating our psychological tendency to normalise, says Rachit Dubey, assistant professor at the department of communication, University of California.
Indian astronaut Shubhanshu Shukla predicts a transformative decade for India’s space exploration and international collaboration.